160357-94-8 Usage
General Description
1-Acetylpiperidin-4-amine, also known as N-Acetyl-4-piperidinamine, is a chemical compound that is commonly used in the synthesis of pharmaceuticals and organic compounds. It is a derivative of piperidine and has a variety of applications in the pharmaceutical industry, particularly in the development of drugs for the treatment of various diseases and conditions. 1-Acetylpiperidin-4-amine has been shown to have potential as an intermediate in the synthesis of antiviral and antitumor drugs, and it has also been investigated for its potential as a building block for the synthesis of other organic compounds. Additionally, 1-Acetylpiperidin-4-amine may have potential uses in other industries such as agrochemicals and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 160357-94-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,0,3,5 and 7 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 160357-94:
(8*1)+(7*6)+(6*0)+(5*3)+(4*5)+(3*7)+(2*9)+(1*4)=128
128 % 10 = 8
So 160357-94-8 is a valid CAS Registry Number.
InChI:InChI=1/C7H14N2O/c1-6(10)9-4-2-7(8)3-5-9/h7H,2-5,8H2,1H3
160357-94-8Relevant articles and documents
Compounds and methods of use
-
, (2021/08/04)
Compounds are provided according to Formula (I): and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein X1, X2, X3, X4, Y, A, L1, L2, R1, R2, R5, m and n are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.
TRICYCLIC COMPOUNDS FOR USE IN TREATMENT OF PROLIFERATIVE DISORDERS
-
, (2018/10/19)
The present invention relates to compounds of Formula (I) as defined herein, and salts, hydrates and solvates thereof. The present invention also relates to pharmaceutical compositions comprising compounds of Formula (I), and to the use of compounds of Formula (I) in the treatment or prevention of PRMT5-mediated disorders, such as cancer.
PYRROLOPYRIMIDINECARBOXAMIDES
-
Page/Page column 236, (2009/10/21)
The compounds of Formula (I) wherein R1, R21, R22, R23, R24, Y and R3 have the meanings as given in the description, the salts thereof, the N-oxides of the compounds and the salts thereof and the stereoisomers of the compounds, the salts, the N-oxides of